Benzinga | Sep 1, 2020 09:23AM EDT

Stifel Maintains Hold on Alexion Pharmaceuticals, Lowers Price Target to $117

Stifel maintains Alexion Pharmaceuticals (NASDAQ:ALXN) with a Hold and lowers the price target from $120 to $117.